ACM
BNR

Asymmetry Capital Management’s Burning Rock Biotech BNR Stock Holding History

Asymmetry Capital Management’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-21,773
Closed -$5.03M – 31
2020
Q4 		$5.03M Buy
21,773
+37
+0.2% +$9.93K 2.29% 17
2020
Q3 		$5.45M Buy
+21,736
New +$5.15M 3.5% 14

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Asymmetry Capital Management's BNR Position: Q1 2021 in Review

Asymmetry Capital Management sold out of Burning Rock Biotech (BNR) in Q1 2021, closing a stake of 21,773 shares — an estimated $5.03M sold.

Asymmetry Capital Management first reported a position in BNR in Q3 2020 and held it in 2 quarters. The position peaked at $5.45M in Q3 2020. 54 funds tracked by Wall St. Rank hold BNR as of Q1 2021.

  • Asymmetry Capital Management reported no remaining Burning Rock Biotech position as of Q1 2021 after selling out during the quarter.
  • Asymmetry Capital Management sold 21,773 Burning Rock Biotech shares in Q1 2021, an estimated $5.03M.
  • Asymmetry Capital Management first reported a position in Burning Rock Biotech in Q3 2020 and held it in 2 quarters.
  • Asymmetry Capital Management's Burning Rock Biotech position peaked at $5.45M in Q3 2020.
  • 54 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2021.

Based on Asymmetry Capital Management's 13F filing for Q1 2021, filed 11 May 2021.